No Data
No Data
No Data
No Data
No Data
Braxia Scientific Reports Q3 Results
Seeking AlphaMar 1 16:26
Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company?
Ontario-based Canadian psychedelics company Braxia Scientific Corp. (OTC:BRAXF) filed its interim financial statements and management discussion for the three and six months ended Sept. 30, 2023. Num
BenzingaDec 5, 2023 04:09
Braxia Scientific Reports Q2 Results
Seeking AlphaNov 30, 2023 21:35
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Psychedelics biotech Cybin (NYSE:CYBN) and UK-based Small Pharma (OTC:DMTTF) announced their definitive arr
BenzingaSep 5, 2023 22:07
Braxia Scientific Faces Challenges In Accessing Public Market Capital, Reports Q1 Loss
Braxia Scientific Corp. (OTC:BRAXF), owner of ketamine therapy clinics and KetaMD telemedicine services for depression and related disorders, has shared its interim financial statements for the three
BenzingaAug 31, 2023 21:28
Braxia Scientific Reports FQ1 Results
Seeking AlphaAug 31, 2023 15:58
No Data
No Data